Clinical Trial Update: Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

This clinical trial update describes the status of a Phase 2 study evaluating glufosfamide in patients with recurrent glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Glufosfamide (glufosfamide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED